FDA Adverse Event Injury Summary report: N

VYPRO MESH UNKNOWN PRODUCT

MDR report key: 8927456 · Received August 23, 2019

Report

Report Number
2210968-2019-86080
Event Type
Injury
Date Received
August 23, 2019
Report Date
July 30, 2019
Manufacturer
ETHICON INC.
Product Code
FTL
PMA / PMN Number
K002672
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SW
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PRODUCT COMPLAINT # (B)(4). THIS REPORT IS RELATED TO A JOURNAL ARTICLE; THEREFORE, NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. THE SINGLE COMPLAINT WAS REPORTED WITH MULTIPLE EVENTS. THERE ARE NO ADDITIONAL DETAILS REGARDING THE ADDITIONAL EVENTS. CITATION: HERNIA (2005) 9: 223¿227; DOI 10.1007/S10029-005-0324-Z. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED IN A JOURNAL ARTICLE WITH TITLE: ONE YEAR RESULTS OF A RANDOMISED CONTROLLED MULTI-CENTRE STUDY COMPARING PROLENE AND VYPRO II-MESH IN LICHTENSTEIN HERNIOPLASTY. THIS INTERNET-BASED STUDY WAS DESIGNED TO COMPARE A STANDARD POLYPROPYLENE MESH WITH THE NEW POLYPROPYLENE/POLYGLACTIN MESH IN THE LICHTENSTEIN OPERATION. FROM DEC 2000 TO APR 2002, 591 MALE PATIENTS WITH UNILATERAL PRIMARY INGUINAL HERNIA WERE RANDOMIZED TO LICHTENSTEIN OPERATION USING PROLENE MESH (N=295; MEAN AGE SD OF 54 YEARS [14 YEARS]) OR VYPRO MESH (N=296; MEAN AGE SD OF 55 YEARS [14 YEARS]). IN THE PROCEDURE, A PIECE OF 7.5X15 CM (PROLENE, ETHICON GMBH, HAMBURG, GERMANY OR VYPRO II, ETHICON GMBH, HAMBURG, GERMANY) MESH WAS USED ACCORDING TO THE ASSIGNMENT. AT 1-YEAR FOLLOW-UP, COMPLICATIONS INCLUDED BULGE IN THE GROIN (N=16 PROLENE GROUP), GROIN PAIN (N=32 PROLENE GROUP), NEURALGIA (N=3 PROLENE GROUP) IN WHICH ONE PATIENT WAS RE-OPERATED WITH NEUROTOMI AFTER 10 WEEKS AND WAS COMPLETELY RECOVERED. IN PROLENE GROUP, RECURRENCE (N=4) WERE TREATED WITH REOPERATION USING PLUG (N=1), TEP (N=2), AND MESH-PLUG (N=1). IN VYPRO II GROUP, RECURRENCES (N=4) WERE TREATED WITH REOPERATION USING MARCY HERNIOPLASTY + MESH (N=1), LICHTENSTEIN (N=1), TEP (N=1) AND MESH PLUG (N=1). IN LICHTENSTEIN¿S OPERATION THERE IS A POSSIBLE RISK OF INJURING OR CATCHING THE SENSORY NERVES (ILEOINGUINAL, GENITAL BRANCH OF GENITOFEMORAL, ILEOHYPOGASTRIC) WHEN SUTURING THE MESH OR DURING THE FIBROBLASTIC IN-GROWTH POST-OPERATIVELY. THE RESULTS OF LICHTENSTEIN¿S OPERATION WITH EITHER PROLENE OR VYPRO II RESULTED IN LOW INCIDENCE OF HERNIA RECURRENCE AND NEURALGIA IN BOTH GROUPS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
718208 VYPRO MESH UNKNOWN PRODUCT MESH, SURGICAL, POLYMERIC FTL ETHICON INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention